Showing results (121-130 of 344) with videos related to

Sort By:
Pageof 35
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 23, 2015
[Transplant-Related Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation Using Fludarabine/Busulfan-Based Reduced-Intensity Conditioning - A Retrospective Analysis in a Single Institution]Takashi Yoshida, Shigeru Kusumoto, Arisa Masuda, et al.
International Journal of Cancer|January 21, 2006
Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factorsAtsushi Inagaki, Takashi Ishida, Toshihiko Ishii, et al.
Journal of Vascular and Interventional Radiology : JVIR|September 27, 2022
Risk Factors Associated with Clinical Failure of Uterine Artery Embolization for Postpartum HemorrhageShinya Kosai, Hiroki Higashihara, Hiroki Yano, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 20, 2016
Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assayNoboru Shinkai, Shigeru Kusumoto, Shuko Murakami, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 2, 2014
[A case of multiple myeloma in a young adult, discovered on the basis of an abnormal finding on a chest X-ray film]Makoto Nakao, Yuu Asao, Yusuke Kagawa, et al.
International Journal of Hematology|December 24, 2024
DREAMM-11, Part 2: Japanese phase I trial of belantamab mafodotin combination therapies in relapsed/refractory multiple myelomaKazutaka Sunami, Shinsuke Iida, Nobuhiro Tsukada, et al.
International Journal of Hematology|April 16, 2022
Pomalidomide, dexamethasone, and daratumumab in Japanese patients with relapsed or refractory multiple myeloma after lenalidomide-based treatmentKosei Matsue, Kazutaka Sunami, Morio Matsumoto, et al.
Plos One|May 9, 2018
Low expression of neural cell adhesion molecule, CD56, is associated with low efficacy of bortezomib plus dexamethasone therapy in multiple myelomaTakashi Yoshida, Masaki Ri, Shiori Kinoshita, et al.
Cancer Science|June 29, 2016
Dose-escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myelomaShinsuke Iida, Daisuke Ogiya, Yasunobu Abe, et al.
International Journal of Hematology|October 31, 2019
Final results of a phase I study of carfilzomib, lenalidomide, and dexamethasone for heavily pretreated multiple myelomaIsamu Sugiura, Kenshi Suzuki, Masaki Ri, et al.
Pageof 35